Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

2.45
Delayed Data
As of Aug 27
 +0.11 / +4.70%
Today’s Change
2.07
Today|||52-Week Range
5.55
+8.41%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close2.34
Today’s open2.40
Day’s range2.40 - 2.50
Volume65,230
Average volume (3 months)118,093
Market cap$33.9M
Dividend yield--
Data as of 3:57pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+3.73%
Earnings growth (this year)+35.54%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+227.65%
P/E ratio--
Price/Sales19.14
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
SNGXSoligenix Inc+0.02+1.63%
OXGNOXiGENE Inc-0.01-0.85%
BPMXBioPharmX Corp+0.05+3.52%
KDUSCadus Corp+0.01+0.88%
Data as of 4:00pm ET, 08/27/2015

Financials

Last reporting dateNovember 7, 2013
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$1.3M
Annual profit (last year)-$14.5M
Net profit margin-1,094.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers